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The generation of in vitro and in vivo models to study human corticogenesis is essential to
address the molecular and cellular mechanisms involved in developmental and degenerative
cortical diseases. We previously found that human pluripotent stem cells (PSC) can
recapitulate major milestones of human corticogenesis in vitro. In addition, following the
transplantation of human PSC-derived cortical cells into the mouse neonatal brain we
observed a functional integration and establishment of specific axonal projections from the
human neurons.
Several neurological diseases strike the integrity of the cerebral cortex including stroke,
epilepsy and neurodegenerative diseases such as Alzheimer’s disease (AD). When some of
these diseases have been extensively studied, mostly they have been tackled using murine
transgenic models that cannot completely recapitulate the etiology of the disease.
Here, we present a novel “in vivo humanized AD model” from human pluripotent stem cells.
We transplanted PSC-derived human cortical neurons into the brain of transgenic AD mouse
models to characterize early and late effects of amyloid pathology on human neurons. We
found that human neurons exposed to the toxic amyloid-beta species in the transgenic
mouse brain show very early signs of neurodegeneration, including aberrant accumulation of
pre-synaptic neurotransmitter vesicles, and early neuronal loss. Signs of neuronal and
axonal degeneration were also observed by EM analysis specifically in the human neurons.
Interestingly, the human neurons located at amyloid-beta plaque sites were positive for
pathological Tau tangle-like staining, a major hallmark of AD. A preliminary comparative RNA
expression analysis at early stages between human neurons transplanted into wild-type and
transgenic animals revealed some differentially expressed candidate genes that could shed
new light on the biology of early stages of the disease.
In conclusion, the humanized model for AD can recapitulate major milestones of the AD
human pathology in an in vivo context and could be instrumental for the study of early and
late stages of the pathology, opening new venues for future research in the field. 
Overall, these data demonstrate that cortical neurons derived from human pluripotent stem
cells represent an invaluable tool for the modeling of human cortical diseases, in particular
adult onset, human specific neurological disorders, such as Alzheimer’s disease.
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